Navitus uses a Pharmacy and Therapeutics (P&T) Committee to make all drug therapy decisions, including step therapy. They evaluate the safety and efficacy of a product, including clinical practice guidelines, based on available medical literature.
Priority is put on current U.S. Guidelines, which:
- Acknowledge any potential conflict of interest
- Describe the methodology of guideline development
- Emphasize inclusion of peer-reviewed publications and evidence-based research
- Incorporate widely-accepted medical practice
When higher-quality guidelines are unavailable, we consider others which:
- Come from organizations outside the U.S.
- Focus primarily on expert or consensus-based opinion
- Lack any of the areas mentioned above
The P&T Committee considers cost only after it makes the clinical determination. Once the medication is evaluated, if a lower cost alternative exists, a step therapy protocol is set up.